Back to news archive
Image for Funding from BIO-X Accelerate Program
Grants & Awards 2020-03-27

Funding from BIO-X Accelerate Program

Gradientech has been awarded with SEK 6.3M from the BIO-X Accelerate program. The funding will support the commercialization journey of its diagnostic system QuickMIC®, by advancing the production transfer of the antibiotic panels, and by securing the clinical performance studies.

Link to press-release

Gradientech is an ISO13485 certified company since 2017


Gradientech AB
Uppsala Science Park
SE-751 83 Uppsala

About Gradientech

Gradientech develops, manufactures and sells innovative microfluidic products for high-quality analysis of the behavior of cells and organisms in response to gradients of biomolecules. Our aim is to pioneer life science and healthcare.

Copyright © 2024 Gradientech. All rights reserved. Gradientech, QuickMIC and CellDirector are registered trademarks or trademarks of Gradientech AB.

Next-generation antimicrobial susceptibility testing

Take a look at our E-book